ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01720836
Recruitment Status : Recruiting
First Posted : November 2, 2012
Last Update Posted : July 30, 2018
Sponsor:
Information provided by (Responsible Party):
Olivera Finn, University of Pittsburgh

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2020
  Estimated Study Completion Date : September 2020